
|Articles|February 1, 2018
- Pharmaceutical Executive-02-01-2018
- Volume 38
- Issue 2
Pharmaceutical Executive, February 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive February 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Pharma's Image Fix: Lessons from the Fieldover 8 years ago
The Innovation Distinction: Biopharma's Reputational Passover 8 years ago
Valeant’s Northern Faceover 8 years ago
More New Drugs and Generics Reshape Pharma Marketsover 8 years ago
Leadership in All the Right Placesover 8 years ago
Industry Engine CheckAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It
2
Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma
3
The New Healthy Aging Imperative and What It Means for Pharma
4
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
5




